outcomes including disrupted neurodevelopment, increased risk of SE recurrence, and increased long term mortality. SE is "refractory" if seizures continue after first-and second-line therapy. Refractory status epilepticus (RSE) is associated with mortality rates as high as 32%. Expedient treatment of SE is essential for achieving good outcomes, however the average time to first-, second-, and third-line treatments are longer than guidelines recommend at US tertiary care hospitals. To address this issue, the American Academy of Neurology proposed as a quality measure, the proportion of pediatric patients receiving third-line treatment for convulsive RSE within 60 minutes. We field-tested this quality measure with the goal of determining whether it is feasible to measure and whether it actually reflects quality of care.
Study Objectives: Diabetes-related ED visits have increased over the past 15 years, and with increasing disease prevalence, these visits will likely continue to rise. To prepare for this anticipated surge in ED care, we must better understand what drives diabetes-related ED visits. In this study, we describe characteristics of patients with poorly controlled diabetes who have high ED utilization, and compare them with patients with lower ED utilization.
Methods: We recruited a cohort of patients with poorly controlled diabetes (glycosylated hemoglobin (HbA1c) 8.5) from an academic urban ED. These patients reported their medication use, ED visits, use of primary care, level of depression, knowledge of hypoglycemia, health literacy and language preference. We examined the association between each of these characteristics and high ED utilization (3+ visits in the prior 6 months) with bivariate analysis. With a multivariate regression model, we adjusted for the individual contributions of these characteristics with high ED utilization.
Results: We recruited 108 patients with diabetes (59% female, 93% Latino ethnicity, 69% Spanish speaking). Of these 108, 31 patients (29%) had more than 2 ED visits in the prior 6 months. The only significant predictor of high ED utilization was use of insulin p<0 .01, see Table 1 ). This association was robust to adjustment for other measured characteristics.
Conclusions: Insulin use is associated with increased ED utilization, and this relationship persists after controlling for knowledge of hypoglycemia, health literacy and other patient characteristics. Insulin use is potentially a marker of severe disease progression and need for intensive health care resources. These patients require extra efforts by case managers and primary care teams to ensure adequate care for these patients and avoid high numbers of ED visits. Study Objectives: Sepsis is a leading cause of mortality in the United States, and the Centers for Medicare and Medicaid have developed a sepsis bundle quality metric focused on a series of timestamped process metrics in an attempt to reduce mortality. We seek to improve the CMS sepsis bundle compliance rate and reduce mortality in the emergency department through the implementation of a nurse-led bedside coaching program.
Odds ratio and adjusted odds ratio of high ED utilization in ED patients
Methods: We developed a pre-and post-intervention observational study to analyze sepsis bundle compliance and mortality rates following the implementation of a nurse-led bedside coaching program. Clinical nurse specialists were trained as sepsis coaches with the aim to respond to the bedside of patients with suspected sepsis. The sepsis coach utilized a bundle compliance checklist to direct and simplify the time dependent multi-step treatment process. Sepsis bundle compliance was tracked for 8 months, including the 4 months prior to implementation and 4 months after implementation of the nurse-led coaching role. Patient records with severe sepsis were audited and analyzed for compliance with sepsis bundle metrics. The primary outcomes measured were sepsis bundle compliance and sepsis-related mortality.
Results: During the 4 months prior to intervention, 204 patients were discharged from the hospital or died with a sepsis-related ICD-10 code. The cumulative mortality rate was 9.8% over this time period, and the baseline sepsis bundle compliance rate was 32% among a random subset of patients (N¼77). The most missed elements were IV fluid (N¼47, 61%) and lactate re-check levels (N¼26, 34%). In the 4 months postimplementation of the nurse-led coach, 291 patients were discharged from the hospital or died with a sepsis-related ICD-10 code. The overall cumulative mortality rate over this time period was 10.9% and was not statistically different to the 4 months prior to implementation (p¼0.7679). However, of 91 patients randomly chosen over this time period, the cumulative bundle compliance was 48.3% regardless of whether a coach was at the bedside (compared to a pre-implementation percent of 32.5%, p-value¼ 0.054). Surprisingly, the cumulative bundle compliance improved for both coached and non-coached patients suggesting an effect beyond direct coaching (68%, p-value ¼ 0.0003 versus 45%, p-value ¼0.1155 respectively compared to the baseline 32.5%).
Conclusions: Overall, sepsis bundle compliance in the post-intervention period was significantly higher than the pre-intervention period following the implementation
